Rezultati pretraživanja
  1. prije 10 sati

    SEC 6-K FSD PHARMA INC. NT

  2. prije 16 sati

    This is a real cannabis deal not a lotto play. Huge hemp and seed selling operation. Take a look

  3. prije 16 sati

    This is a real cannabis deal not a lotto play. Huge hemp and seed selling operation. Take a look

  4. prije 17 sati
  5. .CSE FSD Pharma NASDAQ Chairman & CEO, Dr. Raza Bokhari , to Present at 22nd Annual BIO CEO & Investor Conference on Monday, February 10th in NYC

  6. prije 18 sati

    ~ Voycare is committed to being one of the most trusted medical tourism providers for patients in the Americas and Asia, by prioritizing accessibility, quality assurance and price transparency.

  7. .CSE FSD Pharma NASDAQ Chairman & CEO, Dr. Raza Bokhari , to Present at 22nd Annual BIO CEO & Investor Conference on Monday, February 10th in NYC via

  8. prije 21 sat
  9. prije 22 sata
  10. 41 analysts who cover Uber28 have buy or overweight/ating13 have hold ratingsand 0 have a sell rating with an average price target of $45.51.

    Prikaži ovu nit
  11. prije 23 sata
    Odgovor korisnicima

    im sure that whatever dr. raza bokhari will be presenting at the event will be something for FSD Pharma.

  12. prije 23 sata
  13. prije 24 sata

    ~ Net income was $250,000 in fiscal year 2019, a 15% increase from the previous fiscal year 2018. The increase in net income is a result of increase in gross profit.

  14. Guggenheim analyst Jake Fuller said in a Jan23 note that increased price target to $45 from$40.

  15. Prikaži ovu nit
  16. 5. velj
  17. 5. velj

    FSD Pharma Chairman & final boss to Present at 22nd Annual BIO final boss & Investor Conference in NYC .

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.